Apyx Medical (APYX) Accounts Payables (2010 - 2026)

Apyx Medical (APYX) has reported Accounts Payables for 17 consecutive years, with $2.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables fell 24.3% year-over-year to $2.2 million; the trailing twelve-month figure through Jun 2026 stood at $2.2 million (down 24.3% YoY), and the FY2025 full-year result was $3.1 million, up 16.94% from the prior year.
• Accounts Payables fell to $2.2 million in Q2 2026 per APYX's latest filing, from $2.6 million in the prior quarter.
• Across five years, Accounts Payables topped out at $3.2 million in Q3 2025 and bottomed at $1.9 million in Q1 2023.
• Historically, Accounts Payables has averaged $2.5 million across 5 years, with a median of $2.6 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Accounts Payables tumbled 32.0% in 2022, then jumped 68.23% in 2025.
• Over 5 years, Accounts Payables stood at $2.7 million in 2022, then increased by 1.61% to $2.7 million in 2023, then dropped by 3.58% to $2.6 million in 2024, then grew by 16.94% to $3.1 million in 2025, then declined by 28.38% to $2.2 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $2.2 million, $2.6 million, and $3.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.